The Immune Checkpoint Inhibitors Market is likely to rebound at a significant CAGR of 18.2%. The global market for immune checkpoint inhibitors (ICIs) was growing at a rapid pace and was expected to continue its upward trajectory in the coming years. ICIs are a type of cancer immunotherapy